Background-Homoeopathic pharmacy occupies a distinctive position at the intersection of pharmacognosy, pharmaceutical processing, pharmacopoeial standardization, quality assurance, and clinical practice. The therapeutic use of homoeopathic preparations depends not only on principles of prescribing but also on the authenticity of source materials, reproducibility of manufacturing procedures, appropriate potentization processes, pharmaceutical quality, storage, dispensing, and regulatory compliance. Considerable variation, however, exists internationally in pharmacopoeial standards, manufacturing requirements, terminology, regulatory frameworks, and the clinical evidence supporting homoeopathic interventions.

Objective-The present systematic integrative review aimed to critically examine the relationship between homoeopathic pharmacy and clinical practice, with particular emphasis on pharmaceutical standardisation, source-material identification, drug preparation and potentization, quality assurance, pharmacopoeial and regulatory frameworks, clinical applications, safety considerations, current evidence gaps, and priorities for future research.

Methods: A systematic integrative review framework was developed in accordance with the principles of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020). Literature relevant to homoeopathic pharmaceutical preparation, pharmacopoeial standardization, quality control, manufacturing practices, safety, clinical application, and research methodology was considered through searches of major biomedical and scientific databases and authoritative regulatory and pharmacopoeial resources. Sources were conceptually classified into pharmaceutical standardization, manufacturing and potentization, quality assurance, safety and regulation, clinical evidence, and emerging research. Because of substantial methodological heterogeneity among pharmaceutical, laboratory, regulatory, and clinical literature, findings were synthesized narratively rather than through quantitative meta-analysis.

Results-The reviewed literature indicates that contemporary homoeopathic pharmacy is supported by established pharmacopoeial systems and defined manufacturing procedures in several jurisdictions. Critical pharmaceutical determinants include botanical, chemical, mineral, or biological source authentication; purity testing; preparation of mother tinctures and triturations; control of dilution and potentization procedures; appropriate excipients; contamination prevention; documentation; and stability and storage requirements. International regulatory approaches nevertheless remain heterogeneous. Clinical research is similarly heterogeneous, and current evidence does not establish efficacy across specific diseases with the consistency expected for conventional evidence-based therapeutic recommendations. This distinction between demonstrable pharmaceutical quality and demonstrable clinical effectiveness is fundamental. Emerging analytical approaches may strengthen characterization of preparations, but they should not be interpreted as proof of therapeutic efficacy without corresponding rigorous clinical evidence.

Conclusion: A stronger bridge between homoeopathic pharmacy and clinical medicine requires integration of pharmacopoeial standardization, modern analytical technologies, validated quality-control systems, transparent reporting of preparation methods, rigorous clinical research, pharmacovigilance, and international regulatory dialogue. Future research should prioritize reproducibility, independent replication, multicentre studies, prospective protocol registration, validated outcome measures, batch-level pharmaceutical characterization, and transparent reporting. Such an approach can provide a more scientifically testable framework for evaluating the quality, safety, and clinical relevance of homoeopathic medicinal products.